Legal & General Group Plc - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2016$3,000
-25.0%
11,3940.0%0.00%
Q4 2015$4,000
-78.9%
11,3940.0%0.00%
Q3 2015$19,000
-24.0%
11,3940.0%0.00%
Q2 2015$25,000
+13.6%
11,3940.0%0.00%
Q1 2015$22,000
-26.7%
11,3940.0%0.00%
Q4 2014$30,000
-16.7%
11,3940.0%0.00%
Q3 2014$36,00011,3940.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 21,704,847$5,209,0007.19%
CAXTON CORP 67,000$16,0000.02%
McQueen, Ball & Associates Inc. 102,742$25,0000.02%
TWO SIGMA SECURITIES, LLC 36,056$9,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,398,330$336,0000.01%
WEDBUSH SECURITIES INC 45,000$11,0000.00%
Roundview Capital LLC 21,100$5,0000.00%
Renaissance Technologies 2,332,995$560,0000.00%
PANAGORA ASSET MANAGEMENT INC 618,599$148,0000.00%
Virtu KCG Holdings LLC 107,071$26,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders